2019. Follow-up results of a randomized, double-blind, phase III, multi-center study to evaluate the safety and efficacy of BF-200 ALA versus placebo in field-directed treatment of mild to moderate AK with photodynamic therapy when using narrowband red light. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S49. DOI:https://doi.org/10.25251/skin.3.supp.49.